头头电子竞技

Reliable Quality

Affordable Innovation

Name Indication Clinical Trial Phase Study Title
HLX01
DLBCL
Phase III

Clinical Study to Compare the Efficacy and Safety of Rituximab Biosimilar HLX01 in Combination with CHOP and Rituximab in Combination with CHOP

HLX01
RA
Phase I/II

A Phase 1/2 Study to Evaluate the PK, PD, Safety, and Efficacy between HLX01 and Rituximab in Patients with Rheumatoid Arthritis

HLX01
RA
Phase III

A Phase III Study of Safety and Efficacy of HLX01+MTX in Patients with Moderate to Severe Active Rheumatoid Arthritis